Luke Sergott

Q: What is Luke Sergott's success rate?

Luke Sergott currently has a success rate of 98.91434794347155.

Q: What is the average return of Luke Sergott's calls?

Their stock ratings have generated an average return of 14.277555287016177.

Barclays | Healthcare

Luke Sergott is an analyst from Barclays specializing in the Healthcare sector. Ranked #1038 out of 4697 analysts, they have issued 143 stock ratings with a success rate of 98.91% and an average return of 14.28%.

Luke Sergott has a well-established track record, with 143 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 98.91% and an average return of 14.28%, underscoring their expertise and ability to identify winning opportunities for investors.

#1038

Out of 4697

143

Total Ratings

+98.91%

Success Rate

+14.28%

Average Return

Recent Ratings Analysis

A

Buy

Jun 24, 2026

Target

$150.00

Current

$131.63

Performance

0.00%

Luke Sergott rated A as Overweight on Jun 24, 2026, setting a price target of 150. Shares have remained stable near 131.63, leaving the 150 target still in play.

TXG

Buy

Jun 24, 2026

Target

$40.00

Current

$34.60

Performance

0.00%

On Jun 24, 2026, TXG was given a Overweight rating by Luke Sergott, with a target price of 40. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

TWST

Buy

Jun 24, 2026

Target

$95.00

Current

$91.35

Performance

0.00%

TWST received a Overweight rating from Luke Sergott on Jun 24, 2026, aiming for 95. Price action was muted, as shares hovered around 91.35 despite the bullish outlook.

SHC

Buy

Jun 24, 2026

Target

$19.00

Current

$16.69

Performance

0.00%

On Jun 24, 2026, Luke Sergott published a Overweight outlook on SHC, with a target of 19. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 16.69.

NTRA

Buy

Jun 24, 2026

Target

$260.00

Current

$259.97

Performance

0.00%

Luke Sergott on Jun 24, 2026 assigned NTRA a Overweight rating, with a price target of 260. The recommendation remains pending validation as shares consolidate around 259.97.

ILMN

Sell

Jun 24, 2026

Target

$145.00

Current

$175.09

Performance

0.00%

On Jun 24, 2026, Luke Sergott reaffirmed ILMN with a Underweight rating, targeting 145. Price action has been neutral, giving no verdict on the Sell call.

ICLR

Hold

Jun 24, 2026

Target

$160.00

Current

$158.17

Performance

0.00%

ICLR was rated Equal-Weight by Luke Sergott on Jun 24, 2026, with a price objective of 160. Flat performance suggests the Hold view was reasonable.

GH

Buy

Jun 24, 2026

Target

$150.00

Current

$136.96

Performance

0.00%

On Jun 24, 2026, Luke Sergott initiated coverage on GH with a Overweight rating and target of 150. Neutral price movement of 0.00% leaves room for interpretation.

FTRE

Hold

Jun 24, 2026

Target

$18.00

Current

$17.02

Performance

0.00%

Luke Sergott issued a Equal-Weight recommendation for FTRE on Jun 24, 2026, price target set at 18. The rating was appropriate for a consolidating market trading near 17.02.

BRKR

Buy

Jun 24, 2026

Target

$60.00

Current

$58.44

Performance

0.00%

On Jun 24, 2026, BRKR was evaluated by Luke Sergott, who gave a Overweight rating and target of 60. So far, the Buy call awaits clearer momentum, with shares flat at 58.44.

AVTR

Sell

Jun 24, 2026

Target

$8.00

Current

$9.69

Performance

0.00%

Luke Sergott rated AVTR as Underweight on Jun 24, 2026, setting a price target of 8. So far, the bearish outlook hasn’t materialized, with shares flat near 9.69.

WST

Buy

Jun 09, 2026

Target

$400.00

Current

$340.41

Performance

1.72%

On Jun 09, 2026, WST was given a Overweight rating by Luke Sergott, with a target price of 400. The stock traded sideways with a 1.72% move, keeping the bullish thesis unresolved.

CERT

Hold

May 12, 2026

Target

$6.50

Current

$5.43

Performance

6.68%

CERT received a Equal-Weight rating from Luke Sergott on May 12, 2026, aiming for 6.5. Investors saw gains of 6.68% that the cautious stance didn’t fully capture.

PACB

Sell

May 11, 2026

Target

$1.50

Current

$1.44

Performance

5.88%

On May 11, 2026, Luke Sergott published a Underweight outlook on PACB, with a target of 1.5. Investors who followed the Sell rating avoided losses as the stock weakened.

CRL

Buy

May 08, 2026

Target

$220.00

Current

$202.10

Performance

13.78%

Luke Sergott on May 08, 2026 assigned CRL a Overweight rating, with a price target of 220. The Buy call aligned well with market performance, producing a gain of 13.78%.

WAT

Buy

May 07, 2026

Target

$425.00

Current

$369.18

Performance

5.33%

On May 07, 2026, Luke Sergott reaffirmed WAT with a Overweight rating, targeting 425. The recommendation was supported by strong follow-through as the stock rose from 369.18 to 369.18.

RVTY

Hold

May 07, 2026

Target

$105.00

Current

$105.63

Performance

6.86%

RVTY was rated Equal-Weight by Luke Sergott on May 07, 2026, with a price objective of 105. Despite caution, upside momentum rewarded risk-takers with gains to 105.63.

RGEN

Buy

May 06, 2026

Target

$160.00

Current

$138.40

Performance

10.05%

On May 06, 2026, Luke Sergott initiated coverage on RGEN with a Overweight rating and target of 160. The stock’s climb of 10.05% since the call highlights the foresight in the rating.

QGEN

Hold

Apr 29, 2026

Target

$38.00

Current

$38.73

Performance

15.23%

Luke Sergott issued a Equal-Weight recommendation for QGEN on Apr 29, 2026, price target set at 38. A neutral call gave way to stronger-than-expected performance, closing in on 38.

MEDP

Hold

Apr 24, 2026

Target

$450.00

Current

$512.79

Performance

—

On Apr 24, 2026, MEDP was evaluated by Luke Sergott, who gave a Equal-Weight rating and target of 450. Hold sentiment was validated by subdued trading with no breakout beyond 512.79.

DGX

Buy

Apr 22, 2026

Target

$230.00

Current

$203.11

Performance

-0.44%

Luke Sergott rated DGX as Overweight on Apr 22, 2026, setting a price target of 230. Shares have remained stable near 203.11, leaving the 230 target still in play.

MTD

Buy

Apr 14, 2026

Target

$1500.00

Current

$1203.18

Performance

-10.31%

On Apr 14, 2026, MTD was given a Overweight rating by Luke Sergott, with a target price of 1500. Despite the Buy call, shares fell from 1203.18 to 1203.18, challenging the optimistic stance.

TMO

Buy

Apr 14, 2026

Target

$625.00

Current

$492.20

Performance

-6.64%

TMO received a Overweight rating from Luke Sergott on Apr 14, 2026, aiming for 625. The rating hasn’t played out as hoped, with the stock trading 6.64% below expectations.

DHR

Buy

Apr 14, 2026

Target

$230.00

Current

$188.87

Performance

-4.90%

On Apr 14, 2026, Luke Sergott published a Overweight outlook on DHR, with a target of 230. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 188.87.

IQV

Buy

Mar 06, 2026

Target

$210.00

Current

$185.62

Performance

6.38%

Luke Sergott on Mar 06, 2026 assigned IQV a Overweight rating, with a price target of 210. The Buy call aligned well with market performance, producing a gain of 6.38%.

EXAS

Hold

Nov 21, 2025

Target

$105.00

Current

$104.91

Performance

3.97%

On Nov 21, 2025, Luke Sergott reaffirmed EXAS with a Equal-Weight rating, targeting 105. The neutral call matched muted market action of 3.97%.

INCY

Buy

Aug 01, 2025

Target

$90.00

Current

$108.46

Performance

43.48%

INCY was rated Overweight by Luke Sergott on Aug 01, 2025, with a price objective of 90. A bullish response from the market helped close the gap of -18.46 to the target.

CTLT

Hold

Jun 28, 2024

Target

$63.00

Current

$63.48

Performance

12.89%

On Jun 28, 2024, Luke Sergott initiated coverage on CTLT with a Equal-Weight rating and target of 63. The Hold stance underestimated the stock’s strength as it gained 12.89%.

Frequency Asked Questions

Who is Luke Sergott?

Luke Sergott is an analyst from Barclays specializing in the Healthcare sector.

What is Luke Sergott's success rate?

Luke Sergott currently has a success rate of +98.91%.

How many ratings has Luke Sergott issued?

Luke Sergott has issued 143 stock ratings so far.

What is the average return of Luke Sergott's calls?

Their stock ratings have generated an average return of +14.28%.

What is Luke Sergott's ranking?

Luke Sergott is ranked #1038 out of 4697 analysts.

What types of ratings does Luke Sergott give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Luke Sergott?

You can follow Luke Sergott by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Luke Sergott?

Their latest rating was a Buy on A issued on 2026-06-24.